Cassava Sciences Inc.
News
Cassava Sciences' Richard Barry to take helm as permanent CEO
Seeking Alpha - Healthcare Cassava Sciences' Richard Barry to take helm as permanent CEO...\n more…
Cassava Sciences Names Rick Barry as Chief Executive Officer
Globe Newswire Claude Nicaise, M.D. appointed Chairman of the BoardAUSTIN, Texas, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer's disease...\n more…
Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference
Globe Newswire AUSTIN, Texas, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer's disease, announced today that it has been...\n more…
Cassava Sciences, Inc. (NASDAQ:SAVA) Shares Purchased by Brookstone Capital Management
Ticker Report Brookstone Capital Management grew its holdings in shares of Cassava Sciences, Inc. (NASDAQ:SAVA - Free Report) by 6.0% in the 2nd quarter, according to the company in its most recent disclosure with...\n more…
Cassava Sciences: Volatility Provides Trading Opportunities
SeekingAlpha Cassava Sciences: Volatility Provides Trading Opportunities...\n more…
HC Wainwright Comments on Cassava Sciences, Inc.'s Q3 2024 Earnings (NASDAQ:SAVA)
Ticker Report Cassava Sciences, Inc. (NASDAQ:SAVA - Free Report) - Stock analysts at HC Wainwright dropped their Q3 2024 EPS estimates for shares of Cassava Sciences in a note issued to investors on Tuesday...\n more…